Objective The disease burden in rheumatoid arthritis (RA) extends beyond the joint. This
article evaluates the physical and psychosocial extra-articular burden of treated RA and …

Although treat-to-target has revolutionised the outcomes of patients with rheumatoid arthritis
(RA) there is emerging evidence that attaining the target of remission is insufficient to …

Rheumatoid arthritis (RA) is associated with a wide variety of extra-articular manifestations
and comorbidities, several of which can be organ-or even life-threatening. These extra …

The objective of the study was to develop evidence-based and practical recommendations
for the detection and management of comorbidity in patients with rheumatoid arthritis (RA) in …

While rheumatologists often focus on treatment targets, for many patients with rheumatoid
arthritis (RA), control over pain and fatigue, as well as sustaining physical function and …

Objective Function, patient global assessment, and pain are routinely measured in
rheumatoid arthritis (RA) clinical trials. However, other patient‐reported outcomes identified …

Background The incidence of rheumatoid arthritis (RA) is expected to increase over the next
10 years in the European Union because of the increasing proportion of elderly people. As …

Non-pharmacological treatment modalities are often recommended, prescribed and used in
addition to drug treatment in patients with rheumatoid arthritis (RA). This article provides a …

Rheumatoid arthritis (RA) affects approximately 0.5–1% of the population and imposes
substantial societal costs including an increased risk of work-related disability and …

Despite all improvements in rheumatoid arthritis, we are still not able to prevent or cure the
disease. Diagnostic delays due to lack of access to a specialist and costly therapies are still …